Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes
Muscle Soreness
About this trial
This is an interventional treatment trial for Muscle Soreness focused on measuring Delayed onset muscle soreness, Ultramarathon
Eligibility Criteria
Inclusion Criteria: Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study Male or female, aged 18 or over In good general health as evidenced by readiness to participate in an ultramarathon Ability to take oral medication and be willing to adhere to the study regimen For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening. Exclusion Criteria: Unable to read or understand English Under 18 years of age Pregnancy or lactation Known allergic reactions to components of the investigational drugs
Sites / Locations
- The University of Texas Health Science Center at San AntonioRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Riboflavin Group
Placebo/Control Group
Riboflavin 100mg will be self administered by participants, one capsules prior to the long stage of the race followed by a second dose at the completion of the long stage.
Placebo will be self administered by participants, one capsule prior to the long stage of the race followed by a second dose at the completion of the long stage.